Sam Chun Dang Pharm. Co. Ltd Cash Flow Quality Index
Sam Chun Dang Pharm. Co. Ltd cash flow quality index. Sam Chun Dang Pharm. Co. Ltd (000250) has a Cash Flow Quality Index of 2.86x as of June 2026. Operating cash flow of ₩12.04 Billion exceeds net income of ₩4.21 Billion, indicating high earnings quality where cash backs reported profits. See how financially flexible is Sam Chun Dang Pharm. Co. Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sam Chun Dang Pharm. Co. Ltd (2012–2025)
Cash flow quality index of Sam Chun Dang Pharm. Co. Ltd from 2012 to 2025. Historical Cash Flow Quality Index for Sam Chun Dang Pharm. Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Sam Chun Dang Pharm. Co. Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Sam Chun Dang Pharm. Co. Ltd Cash Flow Quality Index by Year (2012–2025)
Sam Chun Dang Pharm. Co. Ltd cash flow quality index by year from 2012 to 2025. Year-by-year earnings quality comparison for Sam Chun Dang Pharm. Co. Ltd. For the full cash flow conversion analysis, see 000250 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.86x | ₩9.79 Billion | ₩5.26 Billion | ▼ -18.2% |
| 2022 | 2.27x | ₩13.28 Billion | ₩5.84 Billion | ▲ +55.3% |
| 2019 | 1.46x | ₩30.60 Billion | ₩20.89 Billion | ▼ -20.7% |
| 2018 | 1.85x | ₩25.03 Billion | ₩13.55 Billion | ▼ -11.4% |
| 2017 | 2.08x | ₩26.09 Billion | ₩12.51 Billion | ▲ +83.2% |
| 2016 | 1.14x | ₩17.76 Billion | ₩15.61 Billion | ▲ +17.3% |
| 2015 | 0.97x | ₩17.34 Billion | ₩17.87 Billion | ▼ -41.2% |
| 2014 | 1.65x | ₩19.55 Billion | ₩11.85 Billion | ▼ -9.7% |
| 2013 | 1.83x | ₩15.94 Billion | ₩8.72 Billion | ▲ +52.9% |
| 2012 | 1.20x | ₩1.60 Billion | ₩1.34 Billion | — |